Suspended procedures persuant to art. 35a SGB V

Discontinued procedures persuant to art. 35a SGB V

Start Resolution Procedure (no.) Brand name Pharm. company Therapeutic area Indication
Melphalanflufenamid (2, eingestellt) Pepaxti® Oncopeptides AB Oncological diseases Multiple myeloma, refractory, after 2 prior therapies, combination with dexamethasone
Diroximelfumarat (eingestellt) Vumerity® Biogen GmbH Nervous system diseases Multiple Sclerosis (MS)
Belimumab (3) (eingestellt) Benlysta® GlaxoSmithKline GmbH & Co. KG Musculoskeletal system diseases Lupus nephritis
Ceftolozan / Tazobactam (4) (eingestellt) Zerbaxa® MSD SHARP & DOHME GMBH Infectious diseases Ospital-acquired pneumonia, ventilator-associated pneumonia
Ceftolozan / Tazobactam (3) (eingestellt) Zerbaxa® MSD SHARP & DOHME GMBH Infectious diseases Complicated intra-abdominal infections
Ceftolozan / Tazobactam (2) (eingestellt) Zerbaxa® MSD SHARP & DOHME GMBH Infectious diseases Complicated urinary tract infections
Ceftolozan / Tazobactam (eingestellt) Zerbaxa® MSD SHARP & DOHME GMBH Infectious diseases Acute pyelonephritis
Prasteron (eingestellt) Intrarosa® Endoceutics, Inc. Genitourinary system diseases Vulvovaginal atrophy
Ivacaftor (eingestellt) Kalydeco® Vertex Pharmaceuticals (Germany) GmbH Metabolic diseases Cystic fibrosis (CF), ≥ 12 years, combination with tezacaftor (Orphan)
Daratumumab (eingestellt) Darzalex® Janssen Cilag GmbH Oncological diseases Multiple myeloma (MM) (Orphan)
Ibrutinib (eingestellt) Imbruvica® Janssen-Cilag GmbH Oncological diseases Waldenström's disease (Orphan)
Bedaquilin (eingestellt) Sirturo® Janssen-Cilag GmbH Infectious diseases Multidrug-resistant pulmonary tuberculosis (Orphan)
Saxagliptin (eingestellt) Onglyza® Bristol-Myers Squibb GmbH & Co. KGaA / AstraZeneca GmbH Metabolic diseases Diabetes mellitus type 2, monotherapy
Rivaroxaban (eingestellt) Xarelto® Bayer Vital GmbH Cardiovascular diseases Prophylaxis / therapy of artherotrombotic / venothrombotic events
Denosumab (eingestellt) Prolia® Amgen GmbH Musculoskeletal system diseases Osteoporosis (postmenopausal), bone loss (prostate cancer)
Dabigatranetexilat (eingestellt) Pradaxa® Boehringer Ingelheim Pharma GmbH & Co. KG Cardiovascular diseases Prevention of venous thromboembolic events after hip or knee replacement and prevention of stroke and systemic embolism
Parathyroidhormon (eingestellt) PREOTACT® Takeda GmbH Musculoskeletal system diseases Osteoporosis (postmenopausal)
Retigabin (2) (eingestellt) Trobalt® GlaxoSmithKline GmbH & Co. KG Nervous system diseases Epilepsy, focal seizures
Olmesartanmedoxomil / Amlodipin / Hydrochlorothiazid (eingestellt) Sevikar HCT® Daiichi Sankyo Cardiovascular diseases Hypertension

Exempted procedures persuant to art. 35a SGB V

Start Resolution Procedure (no.) Brand name Pharm. company Therapeutic area Indication
Macimorelinacetate (freigestellt) Ghryvelin® Consilient Health Ltd. Metabolic diseases Hypohysis function tests
Indigocarmin (freigestellt) Indigokarmin Serb® SERB SA Genitourinary system diseases Other diagnostics
Lutetium (177Lu) Oxodotreotid (freigestellt) Lutathera® Advanced Accelerator Applications Germany GmbH Oncological diseases Radiotherapy (Orphan)
Landiololhydrochlorid (freigestellt) Rapibloc® Amomed Pharma GmbH Cardiovascular diseases Tachycardia, atrial fibrillation or atrial flutter
Dinutuximab beta (freigestellt) Dinutuximab beta EUSA® EUSA Pharma (Germany) GmbH Oncological diseases Other antineoplastic agents (Orphan)
Delamanid (freigestellt) Deltyba® Otsuka Novel Products GmbH Infectious diseases Infections (Orphan)
Defibrotid (freigestellt) Defitelio® Gentium SpA n.d. Severe hepatic veno-occlusive disease in haematopoietic stem cell transplantation (Orphan)
Chloroprocain (freigestellt) Ampres® Meduna Arzneimittel GmbH n.d. Spinal anaesthesia
Piperaquintetraphosphat / Dihydroartemisinin (freigestellt) Eurartesim® sigma-tau Arzneimittel GmbH n.d. Antimalarial
Ceftarolinfosamil (freigestellt) Zinforo® AstraZeneca GmbH n.d. Beta-lactam antibiotic
Dexmedetomidin (freigestellt) Dexdor® Orion Corporation n.d. Hypnotics and sedatives, parenteral